Dr. Husain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave FL 15
Columbus, OH 43210Phone+1 614-293-3196Fax+1 614-293-4812
Education & Training
- OhioHealth/Riverside Methodist HospitalResidency, Internal Medicine, 2012 - 2015
- Ohio State University College of MedicineClass of 2012
Certifications & Licensure
- OH State Medical License 2012 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients with Metastatic Melanoma and Metastatic Kidney Cancer Start of enrollment: 2025 Apr 30
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Characterizing Cardiotoxicity of FDA-Approved Soft Tissue Sarcoma Targeted Therapies and Immune Checkpoint Inhibitors: A Systematic Review.Mustafa Houmsse, Andrew Muskara, Damaris Pasca, Arnab Roy, Sana Sughra
Cancers. 2025-02-27 - The Association of the Microbiome with Melanoma Tumor Response to Immune Checkpoint Inhibitor Treatment and Immune-Related Adverse Events (NCT05102773).Caroline Dravillas, Nyelia Williams, Marium Husain, Rebecca Hoyd, Ahmed Hussein
Medrxiv. 2025-01-31 - Impact of Tobacco, Marijuana, and Alcohol Use on Overall Survival in Recurrent Metastatic Head and Neck Cancer Patients Treated With Immune Checkpoint Inhibitors.Mohammad Bilal Alsavaf, Majd Issa, Brett G Klamer, Marium Husain, Khaled Dibs
Asia-Pacific Journal of Clinical Oncology. 2024-12-20
Press Mentions
- Making Space for SpiritualityJune 25th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: